» Articles » PMID: 33693894

Evaluating the Potential Impact of Interruptions to Neglected Tropical Disease Programmes Due to COVID-19

Overview
Date 2021 Mar 11
PMID 33693894
Citations 13
Authors
Affiliations
Soon will be listed here.
Citing Articles

Assessing the impact of the COVID-19 pandemic on neglected tropical diseases in India: a perspective.

Zaidi I, Vardha J, Khayum A, Anjum S, Chaudhary S, Bakshi A Front Public Health. 2025; 12():1366484.

PMID: 39744363 PMC: 11688195. DOI: 10.3389/fpubh.2024.1366484.


Innovating Leishmaniasis Treatment: A Critical Chemist's Review of Inorganic Nanomaterials.

Bessa I, DAmato D, Souza A, Levita D, Mello C, da Silva A ACS Infect Dis. 2024; 10(8):2485-2506.

PMID: 39001837 PMC: 11320585. DOI: 10.1021/acsinfecdis.4c00231.


Pandemic justice for and from Latin America.

Rekers R, Luna F Ethica. 2024; 22(1):1-25.

PMID: 38379809 PMC: 10878728. DOI: 10.5007/1677-2954.2023.e97435.


Health systems impacts of the COVID-19 pandemic on malaria control program implementation and malaria burden in Benin: A mixed-method qualitative and mathematical modelling and study.

Hoi A, NTcha L, Duguay C, Accrombessi M, Akinro B, Feng C PLOS Glob Public Health. 2024; 4(2):e0002197.

PMID: 38306342 PMC: 10836704. DOI: 10.1371/journal.pgph.0002197.


Responding to the cuts in UK AID to neglected tropical diseases control programmes in Africa.

Anderson R, Cano J, Hollingsworth T, Deribe-Kassaye K, Zoure H, Kello A Trans R Soc Trop Med Hyg. 2022; 117(3):237-239.

PMID: 36416069 PMC: 9977241. DOI: 10.1093/trstmh/trac109.


References
1.
Toor J, Adams E, Aliee M, Amoah B, Anderson R, Ayabina D . Predicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for Innovation. Clin Infect Dis. 2020; 72(8):1463-1466. PMC: 7543306. DOI: 10.1093/cid/ciaa933. View

2.
Le Rutte E, Coffeng L, Munoz J, de Vlas S . Modelling the impact of COVID-19-related programme interruptions on visceral leishmaniasis in India. Trans R Soc Trop Med Hyg. 2021; 115(3):229-235. PMC: 7928630. DOI: 10.1093/trstmh/trab012. View

3.
Prada J, Stolk W, Davis E, Touloupou P, Sharma S, Munoz J . Delays in lymphatic filariasis elimination programmes due to COVID-19, and possible mitigation strategies. Trans R Soc Trop Med Hyg. 2021; 115(3):261-268. PMC: 7928650. DOI: 10.1093/trstmh/trab004. View

4.
Toor J, Rollinson D, Turner H, Gouvras A, King C, Medley G . Achieving Elimination as a Public Health Problem for Schistosoma mansoni and S. haematobium: When Is Community-Wide Treatment Required?. J Infect Dis. 2019; 221(Suppl 5):S525-S530. PMC: 7289541. DOI: 10.1093/infdis/jiz609. View

5.
Aliee M, Castano S, Davis C, Patel S, Mwamba Miaka E, Spencer S . Predicting the impact of COVID-19 interruptions on transmission of gambiense human African trypanosomiasis in two health zones of the Democratic Republic of Congo. Trans R Soc Trop Med Hyg. 2021; 115(3):245-252. PMC: 7928583. DOI: 10.1093/trstmh/trab019. View